CD4 c.100G>A ;(p.G34R)

Variant ID: 12-6909523-G-A

NM_000616.4(CD4):c.100G>A;(p.G34R)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.

Neuro-Oncology Advances
Wang, Stacie S SS; Davenport, Alexander J AJ; Iliopoulos, Melinda M; Hughes-Parry, Hannah E HE; Watson, Katherine A KA; Arcucci, Valeria V; Mulazzani, Matthias M; Eisenstat, David D DD; Hansford, Jordan R JR; Cross, Ryan S RS; Jenkins, Misty R MR
Publication Date: 2023

Variant appearance in text: CD4: G34R
PubMed Link: 37152812
Variant Present in the following documents:
  • Main text
  • vdad024.pdf
View BVdb publication page



Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location.

Computational And Systems Oncology
Bailey, Cavan P CP; Wang, Ruiping R; Figueroa, Mary M; Zhang, Shaojun S; Wang, Linghua L; Chandra, Joya J
Publication Date: 2021-09

Variant appearance in text: CD4: G34R
PubMed Link: 34723252
Variant Present in the following documents:
  • Main text
View BVdb publication page